Keyphrases
Kidney Disease Progression
100%
Diabetic Kidney Disease
100%
Novel Risk Factors
100%
Chronic Renal Insufficiency Cohort
100%
Diabetes
60%
Risk Factors
60%
Urinary Neutrophil Gelatinase-associated Lipocalin (uNGAL)
60%
Composite Outcome
40%
Independent Risk Factors
40%
N-terminal Pro-brain Natriuretic Peptide (NT-proBNP)
40%
Without Diabetes
40%
Cardiac Markers
40%
Estimated Glomerular Filtration Rate Slope
40%
Chronic Kidney Disease
20%
Systolic Blood Pressure
20%
High Risk
20%
Low Serum
20%
Prospective Cohort Study
20%
Multivariable
20%
Risk Stratification
20%
Cox Proportional Hazards Model
20%
Clinical Centers
20%
Chemokine Ligand 12 (CXCL12)
20%
Stepwise Selection
20%
Estimated Glomerular Filtration Rate
20%
Analytical Approach
20%
Bicarbonate
20%
Opportunity to Use
20%
Kidney Injury molecule-1 (KIM-1)
20%
Linear Mixed Effects
20%
Inflammatory Chemokines
20%
Diabetes Status
20%
Chemokine CXCL12
20%
Causal Inference
20%
High-sensitivity Troponin T
20%
Mechanistic Investigation
20%
Objective Identification
20%
Observational Study Design
20%
Kidney Replacement Therapy
20%
Biochemistry, Genetics and Molecular Biology
Glomerulus Filtration
100%
Cohort Study
100%
Lipocalin
100%
Gelatinase
100%
N-Terminus
66%
Natriuretic Peptide
66%
Cardiac Marker
66%
Systolic Blood Pressure
33%
Troponin T
33%
Stromal Cell-Derived Factor 1
33%
Observational Study
33%
Prospective Cohort Study
33%
Bicarbonate Blood Level
33%
Medicine and Dentistry
Chronic Kidney Disease
100%
Cohort Analysis
100%
Diabetes
66%
Disease Exacerbation
55%
Urinary System
33%
Glomerular Filtration Rate
33%
Neutrophil Gelatinase Associated Lipocalin
33%
Amino Terminal Sequence
22%
Natriuretic Factor
22%
Cardiac Marker
22%
Systolic Blood Pressure
11%
Observational Study
11%
Proportional Hazards Model
11%
Kidney Injury
11%
Prospective Cohort Study
11%
Troponin T
11%
Risk Stratification
11%
Renal Replacement Therapy
11%
Sodium Bicarbonate
11%
Stromal Cell Derived Factor 1
11%
Pharmacology, Toxicology and Pharmaceutical Science
Chronic Kidney Failure
100%
Cohort Study
100%
Disease Exacerbation
55%
Neutrophil Gelatinase Associated Lipocalin
33%
Natriuretic Factor
22%
Replacement Therapy
11%
Kidney Injury
11%
Prospective Cohort Study
11%
Observational Study
11%
Troponin T
11%
Dicarbonate
11%
Stromal Cell Derived Factor 1
11%